Analysis

PremiumFeatures

OCT SoCal 2026: AI know-how, responsible use, and the virtues in taking ownership

Artificial intelligence (AI) is everywhere; it has become a part of our lexicon and daily lives and shows no signs…

PremiumFeatures

Roadmap to recruitment: planning for patients at the start

Features

Podcast: More meaningful partnerships spurring on Chinese biotechs

PremiumFeatures

OCT China: Education key to unlocking DCT adoption in China

Features

Podcast: What’s new in pulmonary fibrosis: Insights from ERS 2026

Projects

Rasonque (daraxonrasib) for the treatment of metastatic PDAC, US

Projects

Apretude (cabotegravir) for the Treatment of HIV-1 Pre-Exposure Prevention (PrEP), US

PremiumFeatures

OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector

Analysis

How real-world evidence can directly support innovation

Analysis

PPD affects races similarly, inequities lie in mental healthcare

GlobalData Healthcare

Analysis

Psychedelic treatments for mental health: Is there substance behind the hype?

News

Can Elon Musk’s Neuralink be trusted to put chips in your brain?

News

IRA lawsuits will be vital test of US’ ability to regulate pharma market

Analysis

How sovereign wealth funds are affecting industries and macroeconomics

Analysis

How sovereign wealth funds are affecting industries and macroeconomics

Analysis

Why does Kuwait struggle to attract FDI?

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close